Vaxa is working with the National Multiple Sclerosis Society to bring awareness to this debilitating disease. Please consider joining us in our efforts.
"Vaxa did a broad body of strategy & tactical work for my team. They worked with us for about three years. On one of their first assignments, Vaxa was asked to recommend a global portfolio of Venture Capital funds we should consider investing in. They presented the analysis to me and my global team at our HQ. Their final recommendations were thorough and compelling, leading us to invest in VC firms in the US, Europe, and the Mid-east."
Wearables and Healthcare
Clinical trials account for 75% of a drug's costs. Wearables can make a sizable dent in driving down the costs and increasing data quality.
Increasing Channel Partner Sales
What do partners need to increase sales? What do vendors need to help partner sell more of their products and solutions? It is not what you think.
MegaTrends - The Next Billion Dollars
In this series of articles, we the work we have been doing on MegaTRENDS, their implications, their pan-industry impact and the growth opportunities they create--in the short and long term.
Channels - Driving Partner Performance
Channel sales is a critical part of driving revenues through partners--for small and large companies. We explore the key drivers of partner performance and how to implement it.
Delivering Lasting Results
Vaxa Inc. is a strategy consulting firm working with leading companies to create lasting growth by increasing revenues. We do this in two ways--by identifying and entering new markets and increasing our clients' share-of-wallet with their existing customers.
We work independently yet collaboratively to uncover the deepest insights to achieve the best results for our clients.
We see first what others see eventually.
SCOPE 2016, Miami
Presenting on the use of wearable biosensors in clinical research.
Tri-Con 2016, San Francisco
Exploring the advances in telemedicine.